Auna S.A.'s SEC filings document a foreign private issuer operating a healthcare services and health-plan platform in Mexico, Peru and Colombia. Current reports on Form 6-K furnish press releases, IFRS financial statements, operating KPIs, annual Form 20-F availability, and updates on healthcare services in Peru, Colombia and Mexico and Oncosalud Peru.
The filing record also covers capital-structure matters, including senior secured notes and completed debt refinancing, as well as material project and agreement disclosures related to the Torre Trecca public-private partnership. These documents frame Auna's results, leverage, segment activity and corporate reporting obligations under its NYSE-listed issuer structure.
AUNA S.A. director Jorge Basadre filed an initial beneficial ownership report on Form 3 indicating he does not beneficially own any securities of the company. The filing identifies his relationship as a director and is signed by attorney-in-fact Carolina Brovelli as of 03/18/2026.
AUNA S.A. director Oscar Leonardo Bacherer Fastoni filed an initial Form 3 reporting his status as a director of the company. The filing does not list any reportable transactions or derivative positions, and the transaction summary shows no buys, sells, exercises, gifts, or other changes in holdings.
AUNA S.A. director Robert Oberrender filed an initial statement of beneficial ownership on Class A Common Shares. He reports holding 67,548 Class A Common Shares directly. A footnote explains this total includes 21,299 common shares underlying outstanding restricted share units, showing both owned shares and equity-based awards.
Auna S.A. reported FY25 revenue of S/4,385 million, essentially flat year-over-year, while Adjusted EBITDA fell 8% to S/917 million with a 20.9% margin. Despite softer profitability, Adjusted Net Income more than doubled to S/336 million and free cash flow rose 35% versus 2024.
Peru led growth with 9% higher revenue and 14% Adjusted EBITDA growth, supported by strong oncology performance and improved medical loss ratios. Colombia grew revenue 5% but saw lower margins after 2024 one-offs. Mexico’s revenue declined 13% and Adjusted EBITDA 26% for the year, though oncology volumes and early 2026 trends show recovery signs.
The company completed a US$825 million refinancing, keeping net leverage at 3.6x Net Debt-to-Adjusted EBITDA and lifting cash to S/335 million. For 2026, Auna guides to roughly 12% FX-neutral growth in both revenue and Adjusted EBITDA, within a 10–14% range, and plans to hold capex near 4% of revenue.
Auna S.A. has executed an addendum to its Public-Private Partnership with EsSalud, formally authorizing construction of Torre Trecca in Lima, which is expected to become Peru’s largest outpatient facility. The 23-story center will have about 59,000 square meters, 145 consultation offices, and 43 treatment rooms.
Once completed, Torre Trecca is expected to expand EsSalud’s healthcare capacity in metropolitan Lima by roughly 20% and handle over three million patient visits per year. Operations are anticipated to start in mid-2028 under a concession running initially to 2046, with potential renewal to 2064.
The PPP structure uses a dedicated project vehicle and ring-fenced cash flows. After opening, EsSalud will make guaranteed minimum monthly payments through certificates that cover fixed and operating costs, creating a predictable revenue stream for Auna. Construction capex is largely reimbursed by EsSalud via progress certificates, limiting Auna’s upfront investment.
AUNA S.A. beneficial ownership disclosure: Reporting Persons state beneficial ownership of 655,538 Class A Ordinary Shares, representing 2.18% of the class, based on June 30, 2025 outstanding shares.
The filing identifies four Reporting Persons—Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Olegario Vázquez Aldir—and explains the ownership chain by which Mr. Vázquez Aldir controls the entities that hold the shares. The cover responses list sole and shared voting and dispositive powers for the reported shares.
Schroder Investment Management Group has reported beneficial ownership of 1,098,509 shares of AUNA S.A., representing 3.7% of the outstanding class of SHS as of 12/31/2025. Schroder Investment Management Group and Schroder Investment Management Limited each report sole voting and sole dispositive power over these shares, with no shared voting or dispositive power.
The holders state that the securities were acquired and are held in the ordinary course of business and not for the purpose, or with the effect, of changing or influencing control of AUNA S.A. The filing confirms that their ownership represents 5 percent or less of the class.
AUNA S.A. received an amended Schedule 13G/A showing that Mexican investor group entities led by Mr. Olegario Vazquez Aldir report beneficial ownership of 2,225,281 Class A Ordinary Shares, or 7.39% of the class. This percentage is based on 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as disclosed in a prior Form 6-K/A.
The filing aggregates holdings of Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Vazquez Aldir through a control chain in which GASS is the direct holder. The reporting persons certify the shares were not acquired to change or influence control of AUNA S.A.
Grupo Angeles Servicios de Salud and related parties report a 13.10% beneficial stake in AUNA S.A.’s Class A shares. The group reports beneficial ownership of 3,943,170 Class A Ordinary Shares, based on 30,095,388 shares outstanding as of June 30, 2025, as cited from a prior Form 6-K/A.
The reporting persons are Grupo Angeles Servicios de Salud, Grupo Vazol, Corpvaza and Mr. Olegario Vazquez Aldir, all organized or resident in Mexico. Mr. Vazquez Aldir directly controls Corpvaza, which controls Grupo Vazol, which is the parent of Grupo Angeles Servicios de Salud, the direct holder of the AUNA shares.
For the entities, voting and dispositive power over 3,943,170 shares is reported as shared, while Mr. Vazquez Aldir reports sole voting and dispositive power over the same amount. They certify the securities were not acquired to change or influence control of AUNA S.A.
Auna S.A. received a Schedule 13G reporting that a group of related Mexican entities and an individual investor together beneficially own 5,469,898 Class A Ordinary Shares, representing 18.18% of this share class. The direct holder is Grupo Angeles Servicios de Salud, S.A. de C.V., which is controlled through a chain of companies up to Mr. Olegario Vazquez Aldir.
The ownership percentage is calculated using 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as cited from a prior company report. The reporting group previously filed on Schedule 13D but now reports that it holds less than 20% of the outstanding Class A shares and certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of Auna S.A.